{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:49:03Z","timestamp":1792900143046,"version":"4.5.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Long COVID (LC), a clinical condition marked by persistent and new symptoms after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects up to 10-20% of infected individuals. Although autoimmunity has been proposed as a key mechanism, the specific role of circulating autoantibodies in LC remains unclear. We characterized the autoantibody profiles in individuals with LC and assessed their association with persistent post-COVID symptoms, in comparison to recovered patients and pre-pandemic healthy controls (PPHC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 17 autoantibodies in a cohort of 220 pre-pandemic controls and 291 COVID-19 patients, targeting self-antigens. Of those, 237 patients presented symptoms for a month or more after the onset of SARS-CoV-2 infection (long COVID patients), and 54 individuals recovered from the initial infection without chronic symptoms. Autoantibody frequencies and associations with clinical variables were assessed using logistic regression and subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Autoantibody prevalence was higher in recovered individuals (37%) than in LC patients (24%) or PPHC (19%). While certain autoantibodies such as a-cardiolipin (a-CL) IgM, a-AML IgG, a-SSA IgG and a-SSB IgG were elevated in some COVID-19 patients, they were not significantly different in LC. The most frequently detected autoantibody was a-CL IgM, found across all groups and especially in individuals that fully recovered from COVID-19. However, a-CL did not differentiate individuals with long COVID or correlate with symptom persistence but was associated with the occurrence of dysphagia and anorexia as symptoms. No correlation was observed between autoantibody presence and disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings do not support a primary pathogenic role for the evaluated autoantibodies in LC and emphasize the need for longitudinal studies to explore their temporal dynamics and interaction with other immunological or clinical factors involved in post-COVID-19 conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1684482","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:35:44Z","timestamp":1765434944000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Autoantibodies in long COVID in a black\/mixed population compared with recovered and pre-pandemic controls"],"prefix":"10.3389","volume":"16","author":[{"given":"Jessica","family":"de Jesus Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Sampaio","family":"Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayonara Melo","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz","family":"Caz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Antas Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blenda de Jesus","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdcaro","family":"Bonyek-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nunes de Oliveira Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda Isis Lima","family":"de Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juqueline","family":"Rocha Cristal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Cerqueira-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelen Cristina Ribeiro","family":"Malmegrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aquiles","family":"Camelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Ribeiro de Barros","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Machado","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel","family":"Barral-Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldina","family":"Barral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynara","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Sampaio","family":"Boaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"B1","unstructured":"Coronavirus disease (COVID-19) situation reports"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1116131","article-title":"Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00218-6","article-title":"The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity","volume":"9","author":"Osuchowski","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"121531","DOI":"10.1016\/j.lfs.2023.121531","article-title":"Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases","volume":"319","author":"Sher","year":"2023","journal-title":"Life Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169515","article-title":"Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients","volume":"8","author":"Bodansky","year":"2023","journal-title":"JCI Insight"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1509289","article-title":"Autoantibodies in COVID-19: implications for disease severity and clinical outcomes","volume":"15","author":"Galipeau","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2\u2013triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.04.22274681","article-title":"Longitudinal analysis reveals elevation then sustained higher expression of autoantibodies for six months after SARS-CoV-2 infection","author":"Badhelia","year":"2022","journal-title":"medRxiv: Preprint Server Health Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14994","article-title":"Antiphospholipid antibodies in patients with COVID-19: A relevant observation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemostasis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.41425","article-title":"Antiphospholipid antibodies in critically ill patients with COVID-19","volume":"72","author":"Xiao","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.celrep.2022.110873","article-title":"Serum autoantibodyome reveals that healthy individuals share common autoantibodies","volume":"39","author":"Shome","year":"2022","journal-title":"Cell Rep"},{"key":"B14","article-title":"Centers for Disease Control and Prevention (CDC)","volume-title":"COVID-19: Long COVID basics","year":"2025"},{"key":"B15","doi-asserted-by":"publisher","first-page":"109845","DOI":"10.1016\/j.clim.2023.109845","article-title":"Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk","volume":"257","author":"Emmenegger","year":"2023","journal-title":"Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12985-023-02191-z","article-title":"Prevalence, clinical significance, and persistence of autoantibodies in COVID-19","volume":"20","author":"Lee","year":"2023","journal-title":"Virol J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2023.01.016","article-title":"Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19","volume":"115","author":"Jacobs","year":"2023","journal-title":"J Natl Med Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07997-1","article-title":"Racial\/ethnic disparities in post-acute sequelae of SARS-coV-2 infection in new york: an EHR-based cohort study from the RECOVER program","volume":"38","author":"Khullar","year":"2023","journal-title":"J Gen Intern Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100091","DOI":"10.1016\/j.focus.2023.100091","article-title":"Prevalence and characteristics of long COVID 7\u201312 months after hospitalization among patients from an urban safety-net hospital: A pilot study","volume":"2","author":"Hua","year":"2023","journal-title":"AJPM Focus."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1186\/s12889-024-19567-7","article-title":"Long COVID impacts: the voices and views of diverse Black and Latinx residents in Massachusetts","volume":"24","author":"Sprague Martinez","year":"2024","journal-title":"BMC Public Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.03.21251069","article-title":"Risk factors for infection and health impacts of the COVID-19 pandemic in people with autoimmune diseases","volume":"74","author":"Fitzgerald","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100073","DOI":"10.1016\/j.jtauto.2020.100073","article-title":"Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19)","volume":"3","author":"Lerma","year":"2020","journal-title":"J Trans Autoimmunity."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220206","article-title":"Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients","volume":"80","author":"Trahtemberg","year":"2021","journal-title":"Ann Rheumatic Diseases."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100091","article-title":"Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19","volume":"4","author":"Anaya","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2200413119","DOI":"10.1073\/pnas.2200413119","article-title":"The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies","volume":"119","author":"Manry","year":"2022","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1058772","article-title":"Role of autoantibodies targeting type I interferons in COVID-19 severity: A meta-analysis","volume":"14","author":"Gupta","year":"2023","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3390\/ijms26041751","article-title":"Identification of putative serum autoantibodies associated with post-acute sequelae of COVID-19 via comprehensive protein array analysis","volume":"26","author":"Hatayama","year":"2025","journal-title":"IJMS."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.017","article-title":"Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism","volume":"192","author":"Galeano-Valle","year":"2020","journal-title":"Thromb Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"102947","DOI":"10.1016\/j.autrev.2021.102947","article-title":"Post-COVID syndrome. A case series and comprehensive review","volume":"20","author":"Anaya","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218009","article-title":"Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19","volume":"79","author":"Vlachoyiannopoulos","year":"2020","journal-title":"Ann Rheumatic Diseases."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1038\/s41467-021-27887-0","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"13","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920627","article-title":"Long COVID patients exhibit attenuated antibody and T cell responses to SARS-CoV-2 infection and vaccination","volume":"13","author":"Le Bert","year":"2022","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"103445","DOI":"10.1016\/j.autrev.2023.103445","article-title":"Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors","volume":"22","author":"Seibert","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981532","article-title":"Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity","volume":"13","author":"Sotzny","year":"2022","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"107289","DOI":"10.1016\/j.ijid.2024.107289","article-title":"Autoantibodies directed against interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 are not induced by SARS-CoV-2 or associated with long COVID","volume":"150","author":"Epstein-Shuman","year":"2025","journal-title":"Int J Infect Diseases."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.10.001","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and infections","volume":"7","author":"S\u00e8ne","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/antib5020014","article-title":"A clinical approach for defining the threshold between low and medium anti-cardiolipin antibody levels for QUANTA flash assays","volume":"5","author":"Lakos","year":"2016","journal-title":"Antibodies."},{"key":"B39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13075-021-02515-w","article-title":"Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study","volume":"23","author":"Jiang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-phospholipid antibodies in COVID-19 are different from those detecta ble in the anti-phospholipid syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41419-021-03527-9","article-title":"Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis","volume":"12","author":"Nardacci","year":"2021","journal-title":"Cell Death Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/art.42094","article-title":"Endothelial cell\u2013activating antibodies in COVID-19","volume":"74","author":"Shi","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s44324-024-00038-x","article-title":"Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases","volume":"2","author":"Madsen","year":"2024","journal-title":"NPJ Metab Health Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067179","article-title":"Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells","volume":"8","author":"Thammasri","year":"2013","journal-title":"Bob\u00e9 P editor. PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.311.6053","article-title":"Assessment of the frequency of autoantibodies in chronic viral hepatitis","volume":"31","author":"Acay","year":"2014","journal-title":"Pak J Med Sci"},{"key":"B47","article-title":"Autoantibodies and human immunodeficiency viruses infection: A case- control study","volume":"21","author":"Chretien","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"B48","article-title":"COVID-19 and antiphospholipid antibodies: time for a reality check","volume":"48","author":"Favaloro","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0276771","DOI":"10.1371\/journal.pone.0276771","article-title":"Metabolic disorders and post-acute hospitalization in black\/mixed-race patients with long COVID in Brazil: A cross-sectional analysis","volume":"17","author":"Barreto","year":"2022","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1684482\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:35:47Z","timestamp":1765434947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1684482\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2025.1684482"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1684482","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"article-number":"1684482"}}